Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma × Nivolumab × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 130 Carcinoma, Non-Small-Cell Lung 46 Carcinoma, Transitional Cell 41 Melanoma 38 Urinary Bladder Neoplasms 36 Kidney Neoplasms 28 Prostatic Neoplasms 27 Neoplasm Metastasis 23 Colorectal Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Carcinoma, Hepatocellular 17 Triple Negative Breast Neoplasms 13 Stomach Neoplasms 13 Ovarian Neoplasms 11 Neoplasms 11 Clear-cell metastatic renal cell carcinoma 11 Uterine Cervical Neoplasms 10 Carcinoma, Merkel Cell 10 Small Cell Lung Carcinoma 9 Lung Neoplasms 9 Pancreatic Neoplasms 8 Head and Neck Neoplasms 8 Esophageal Neoplasms 6 Cholangiocarcinoma 6 Breast Neoplasms 6 Skin Neoplasms 5 Recurrence 5 Penile Neoplasms 5 Mesothelioma 5 Carcinoma, Squamous Cell 5

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡